BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,309,543 | -10.9% | 137,611 | +18.3% | 0.01% | 0.0% |
| Q2 2023 | $3,715,373 | +11.6% | 116,360 | +7.0% | 0.01% | 0.0% |
| Q1 2023 | $3,330,169 | -6.7% | 108,758 | +19.2% | 0.01% | 0.0% |
| Q4 2022 | $3,569,255 | -18.6% | 91,262 | -0.9% | 0.01% | -30.0% |
| Q3 2022 | $4,384,000 | +25.6% | 92,061 | +2.0% | 0.01% | +42.9% |
| Q2 2022 | $3,491,000 | -32.4% | 90,212 | -0.0% | 0.01% | -22.2% |
| Q1 2022 | $5,167,000 | -27.4% | 90,220 | +1.0% | 0.01% | -18.2% |
| Q4 2021 | $7,117,000 | +15.2% | 89,326 | +25.8% | 0.01% | +10.0% |
| Q3 2021 | $6,179,000 | -21.2% | 71,023 | +16.6% | 0.01% | -23.1% |
| Q2 2021 | $7,840,000 | +258.0% | 60,917 | +122.5% | 0.01% | +225.0% |
| Q1 2021 | $2,190,000 | +362.0% | 27,380 | +370.9% | 0.00% | +300.0% |
| Q4 2020 | $474,000 | – | 5,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |